Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Quarterly results Appointed director CC transcript
|
EMISPHERE TECHNOLOGIES INC (EMIS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/26/2012 |
GN
| Emisphere Technologies, Inc. Announces Default on Approximately $31.1 Million Notes Due to MHR Fund Management LLC and Its Affiliated Funds; MHR Has Not Demanded Payment; The Company and MHR Continue Discussions |
09/17/2012 |
GN
| Emisphere Technologies, Inc. Appoints Alan L. Rubino as President and Chief Executive Officer and Timothy G. Rothwell as Chairman of the Board of Directors; Announces New Corporate Strategy |
08/07/2012 |
GN
| Emisphere Technologies, Inc. Announces Financial Results for the Second Quarter Ended June 30, 2012 |
08/02/2012 |
GN
| Emisphere Technologies, Inc. Announces Second Quarter 2012 Earnings Conference Call |
05/04/2012 |
GN
| Emisphere Technologies, Inc. Announces First Quarter 2012 Earnings Conference Call |
03/21/2012 |
GN
| Emisphere Technologies, Inc. Announces Financial Results for Fourth Quarter and Year Ended December 31, 2011 |
03/15/2012 |
GN
| Emisphere Technologies, Inc. Announces Fourth Quarter and Year End 2011 Earnings Conference Call |
12/14/2011 |
GN
| Emisphere Technologies, Inc. Reports Update on the Clinical Development of Oral Calcitonin in Osteoarthritis and Osteoporosis |
11/14/2011 |
GN
| Emisphere Technologies, Inc. Reports Notification of First Interpretable Results on Phase III Study of Oral Calcitonin in Osteoporosis Patients |
11/08/2011 |
GN
| Emisphere Technologies, Inc. Announces Financial Results for Third Quarter 2011 |
10/13/2011 |
GN
| Emisphere Technologies, Inc. Reports Notification of First Interpretable Results on 2nd Phase III Study of Oral Calcitonin in Osteoarthritis Patients |
06/30/2011 |
GN
| Emisphere Technologies Announces Agreements to Raise $7.5 Million in Private Placement Transactions |
06/17/2011 |
GN
| Emisphere Receives Notice of Results From Collaborator's Proof of Concept Study for Oral PTH for the Treatment of Postmenopausal Osteoporosis |
05/10/2011 |
GN
| Emisphere Technologies, Inc. Announces Financial Results for First Quarter 2011 |
05/06/2011 |
GN
| Emisphere Technologies, Inc. Announces First Quarter 2011 Earnings Conference Call |
03/31/2011 |
GN
| Emisphere Technologies, Inc. Announces Financial Results for Fourth Quarter and Year Ended December 31, 2010 |
03/30/2011 |
GN
| Emisphere Announces Earnings Conference Call for Fourth Quarter and Year Ended December 31, 2010 |
03/14/2011 |
GN
| Emisphere Technologies, Inc. Announces Postponement of Annual Earnings Release and Conference Call |
03/08/2011 |
GN
| Emisphere Announces Fourth Quarter and Full Year 2010 Earnings Conference Call |
02/28/2011 |
GN
| Emisphere Technologies and Michael V. Novinski Mutually Agree to the Non-Renewal of Employment Contract |
12/21/2010 |
GN
| Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for Diabetes |
11/10/2010 |
GN
| Emisphere Technologies Announces Financial and Operational Results for the Third Quarter and First Nine Months of 2010 |
11/04/2010 |
GN
| Emisphere Technologies, Inc. Announces Third Quarter 2010 Earnings Conference Call |
10/22/2010 |
GN
| Emisphere Technologies Reports Notification of Top Level Results on Phase III Study of Oral Calcitonin in Osteoarthritis Patients |
09/17/2010 |
GN
| Emisphere Reports Positive Clinical Results for Its Oral Drug Delivery Technology in Appetite Suppression Study |
08/25/2010 |
GN
| Emisphere Technologies Announces Agreements to Raise $7 Million in Private Placement Transactions |
08/16/2010 |
GN
| Emisphere Announces Financial and Operational Results for the Second Quarter and First Six Months of 2010 |
08/09/2010 |
GN
| Emisphere Announces Second Quarter 2010 Earnings Conference Call |
08/09/2010 |
GN
| Emisphere Announces Second Quarter 2010 Earnings Conference Call |
07/23/2010 |
GN
| Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin |
07/23/2010 |
GN
| Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin |
07/16/2010 |
GN
| Emisphere Technologies Provides Update on High Dose Oral Eligen(R) B12 |
07/16/2010 |
GN
| Emisphere Technologies Provides Update on High Dose Oral Eligen(R) B12 |
05/18/2010 |
GN
| Emisphere Announces 2010 Annual Meeting of Shareholders Scheduled for Tuesday, May 25, 2010 |
|
|
|